Barclays
DPLO

Barclays’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Barclays’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-62,100
Closed -$919K – 7173
2017
Q2 		$919K Buy
+62,100
New +$1.04M ﹤0.01% 2960
2015
Q4 		– Sell
-67,800
Closed -$1.9M – 6866
2015
Q3 		$1.9M Buy
+67,800
New +$2.9M ﹤0.01% 2174

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Barclays's DPLO Position: Q1 2020 in Review

Barclays sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 424,121 shares — an estimated $1.7M sold.

Barclays first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $2.51M in Q3 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Barclays reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Barclays sold 424,121 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.7M.
  • Barclays first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
  • Barclays's DIPLOMAT PHARMACY, INC. position peaked at $2.51M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Barclays's 13F filing for Q1 2020, filed 13 May 2020.